Viewing Study NCT04975061


Ignite Creation Date: 2025-12-24 @ 12:37 PM
Ignite Modification Date: 2026-01-13 @ 10:55 AM
Study NCT ID: NCT04975061
Status: UNKNOWN
Last Update Posted: 2021-07-23
First Post: 2021-07-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Clinical Study of YY-20394 in Patients With Relapsed/Refractory Thymic Cancer
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module